logo
logo

Sanyou Biopharmaceuticals Completes Series B Financing And Secures Its Leading Role In Innovative Antibody Drug Discovery

Jun 26, 2021•about 4 years ago

Round Type

series b

Shanghai

Description

Sanyou Biopharmaceutical (Shanghai) Co., Ltd. (hereafter referred to as "Sanyou Bio" or "the Company"), a leading company in innovative antibody drug discovery, announced the closing of series B financing. This financing round was co-led by LH Ventures and Montesy Investment, and followed by Grand Mount Capital and Seeking Capital (an existing investor). After this round of financing, Zhiyin Lan, venture partner of LH Ventures, will join the Board of Directors of Sanyou Bio

Company Information

Company

Sanyou Biopharmaceuticals

Location

Shanghai, Shanghai, China

About

As of May. 2021, the company has more than 160 members in a professional team, of which the proportion of doctors and masters is more than 70%.